Literature DB >> 23064258

Selective brain gray matter atrophy associated with APOE ε4 and MAPT H1 in subjects with mild cognitive impairment.

Joaquín Goñi1, Sebastián Cervantes, Gonzalo Arrondo, Isabel Lamet, Pau Pastor, María A Pastor.   

Abstract

The aim of our study was to elucidate whether specific patterns of gray matter loss were associated with apolipoprotein E ε4 (APOE ε4) and microtubule-associated protein tau (MAPT)-H1) genetic variants in subjects with mild cognitive impairment (MCI) at a baseline visit. Gray matter voxel-based morphometry analysis of T1 magnetic resonance imaging scans were performed in 65 amnestic-MCI subjects. MCI APOE ε4 carriers compared with non-carriers showed increased brain atrophy in right hippocampus and rostral amygdala, superior and middle temporal gyrus, and right parietal operculum, including inferior frontal gyrus, inferior parietal, and supramarginal gyrus. MAPT-H1/H1 MCI carriers showed an increased bilateral atrophy in superior frontal gyri (including frontal eye fields and left prefrontal cortex) and precentral gyrus but also unilateral left atrophy in the inferior temporal gyrus and calcarine gyrus. In addition, MCI subjects carrying both APOE ε4 and MAPT-H1/H1 variants showed gray matter loss in the supplementary motor area and right pre- and postcentral gyri. The effect of APOE ε4 on gray matter loss in right hippocampus suggests that, at least in some AD sub-types, the neuronal vulnerability could be increased in the right hemisphere. The pattern of frontal gray matter loss observed among MCI MAPT H1/H1 carriers has also been found in other tauopathies, suggesting that MCI may share etiological factors with other tauopathies. Frontal and parietal cortex vulnerability was found when adding MAPT H1/H1 and APOE ε4 effects, suggesting a synergistic effect of these variants. These results could be due to changes in APOE ε4 and MAPT expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23064258     DOI: 10.3233/JAD-2012-121174

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  11 in total

1.  The power of neuroimaging biomarkers for screening frontotemporal dementia.

Authors:  Corey T McMillan; Brian B Avants; Philip Cook; Lyle Ungar; John Q Trojanowski; Murray Grossman
Journal:  Hum Brain Mapp       Date:  2014-03-31       Impact factor: 5.038

2.  Associations Between ApoEε4 Carrier Status and Serum BDNF Levels--New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer's Disease.

Authors:  Yu-Hui Liu; Shu-Sheng Jiao; Ye-Ran Wang; Xian-Le Bu; Xiu-Qing Yao; Yang Xiang; Qing-Hua Wang; Lin Wang; Juan Deng; Jing Li; Xin-Fu Zhou; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Mol Neurobiol       Date:  2014-07-02       Impact factor: 5.590

3.  Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.

Authors:  Elkin O Luis; Sara Ortega-Cubero; Isabel Lamet; Cristina Razquin; Carlos Cruchaga; Bruno A Benitez; Elena Lorenzo; Jaione Irigoyen; Maria A Pastor; Pau Pastor
Journal:  Neurobiol Aging       Date:  2014-06-17       Impact factor: 4.673

4.  Apolipoprotein E gene polymorphism, trauma burden, and posttraumatic stress symptoms in U.S. military veterans: Results from the National Health and Resilience in Veterans Study.

Authors:  Natalie P Mota; Shizhong Han; Ilan Harpaz-Rotem; Paul Maruff; John H Krystal; Steven M Southwick; Joel Gelernter; Robert H Pietrzak
Journal:  Depress Anxiety       Date:  2017-11-24       Impact factor: 6.505

5.  Regional vulnerability in Alzheimer's disease: The role of cell-autonomous and transneuronal processes.

Authors:  Diana Acosta; Fontasha Powell; Yize Zhao; Ashish Raj
Journal:  Alzheimers Dement       Date:  2018-01-04       Impact factor: 21.566

6.  APOE*E4 Is Associated with Gray Matter Loss in the Posterior Cingulate Cortex in Healthy Elderly Controls Subsequently Developing Subtle Cognitive Decline.

Authors:  S Haller; M-L Montandon; C Rodriguez; M Ackermann; F R Herrmann; P Giannakopoulos
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-11       Impact factor: 3.825

7.  Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.

Authors:  R S Desikan; A J Schork; Y Wang; A Witoelar; M Sharma; L K McEvoy; D Holland; J B Brewer; C-H Chen; W K Thompson; D Harold; J Williams; M J Owen; M C O'Donovan; M A Pericak-Vance; R Mayeux; J L Haines; L A Farrer; G D Schellenberg; P Heutink; A B Singleton; A Brice; N W Wood; J Hardy; M Martinez; S H Choi; A DeStefano; M A Ikram; J C Bis; A Smith; A L Fitzpatrick; L Launer; C van Duijn; S Seshadri; I D Ulstein; D Aarsland; T Fladby; S Djurovic; B T Hyman; J Snaedal; H Stefansson; K Stefansson; T Gasser; O A Andreassen; A M Dale
Journal:  Mol Psychiatry       Date:  2015-02-17       Impact factor: 15.992

8.  Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.

Authors:  Guan-Qun Chen; Can Sheng; Yu-Xia Li; Yang Yu; Xiao-Ni Wang; Yu Sun; Hong-Yan Li; Xuan-Yu Li; Yun-Yan Xie; Ying Han
Journal:  BMC Neurol       Date:  2016-05-12       Impact factor: 2.474

9.  Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.

Authors:  Farshad Falahati; Daniel Ferreira; J-Sebastian Muehlboeck; Maria Eriksdotter; Andrew Simmons; Lars-Olof Wahlund; Eric Westman
Journal:  Neuroimage Clin       Date:  2017-08-14       Impact factor: 4.881

10.  APOE Genotype Effects on Intrinsic Brain Network Connectivity in Patients with Amnestic Mild Cognitive Impairment.

Authors:  Zan Wang; Zhengjia Dai; Hao Shu; Xuhong Liao; Chunxian Yue; Duan Liu; Qihao Guo; Yong He; Zhijun Zhang
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.